Breaks Categories: News

WednesdayJul 19, 2023 2:32 pm

NetworkNewsBreaks – ECGI Holdings Inc. (ECGI) Reports on Growth of Soon-to-be-Acquired 8-Bit Cannabis Brand

ECGI Holdings (OTC: ECGI), D/B/A Elite Cannabis Group Incorporated, a Nevada -based portfolio company pivoting into the legal cannabis and cannabinoid marketplace, is releasing an update regarding the expansion of 8-Bit Buds, its soon-to-be-acquired cannabis brand. According to the announcement, the 8-bit cannabis brand has grown from 20 cannabis stores to 62 cannabis stores in the past four months, an impressive 225% increase in distribution footprint. In addition, the company showed strong topline growth during the same period. According to the report, the company is also preparing to launch a new pre-roll cannabis product line designed to support continued growth as well…

Continue Reading

WednesdayJul 19, 2023 2:24 pm

NetworkNewsBreaks – First Tellurium Corp. (CSE: FTEL) (OTC: FSTTF) Poised as Domestic Supplies of Tellurium Become More Critical

First Tellurium (CSE: FTEL) (OTC: FSTTF) today announced that, according to a recent article in PV Magazine, expanded restrictions on Chinese polysilicon solar modules by the U.S. Customs and Border Patrol may result in a near total ban on modules entering the U.S. from China. According to the announcement, these restrictions will place even more pressure on domestic solar companies like First Solar, North America’s largest solar panel manufacturer that produces cadmium telluride modules rather than crystalline polysilicon. “We’re approaching a critical phase in the domestic supply chain for cadmium telluride solar panels,” said Tyrone Docherty, First Tellurium’s president and…

Continue Reading

WednesdayJul 19, 2023 2:05 pm

NetworkNewsBreaks – Mushrooms Inc. (MSRM) Featured in Psychedelic Spotlight Podcast

Mushrooms Inc. (OTC: MSRM) today announced that the company’s CEO Kimberly Carlson recently appeared on the esteemed Psychedelic Spotlight Podcast to discuss the exciting potential of the industrial mushroom industry. Mushrooms Inc., the first company trading on the U.S. stock market focused on the industrial side of mushrooms, is leading the way in revolutionizing this emerging sector. During the podcast episode hosted by David Flores, the CEO of Psychedelic Spotlight, Carlson shared insights into the vision and mission of Mushrooms Inc. The company, with a commitment to environmentally beneficial products, is dedicated to supporting the growth of the mushroom industry…

Continue Reading

WednesdayJul 19, 2023 1:57 pm

NetworkNewsBreaks – CISO Global Inc. (NASDAQ: CISO) Announces Strategic Acquisition of SB Cyber Technologies LLC

CISO Global Inc. (NASDAQ: CISO), an industry leader as a managed cybersecurity and compliance provider, today announced that it has acquired SB Cyber Technologies, a cybersecurity company that specializes in identifying, enhancing and applying emerging government and military grade capabilities to critical commercial technical security challenges. Under the agreement, SC Cyber has become a wholly owned subsidiary of CISO Global. Based in Chesapeake, Virginia, and founded by former members of the U.S. intelligence and special operations communities, SB Cyber developed CHECKLIGHT(R), a powerful and proactive endpoint detection and response (“EDR”) technology that detects potential threats to endpoints, such as laptops…

Continue Reading

WednesdayJul 19, 2023 1:44 pm

NetworkNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces $7.5M Registered Direct Offering

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced its entry into definitive agreements with health care-focused institutional investors. The agreements are for the sale and issuance of 7,425,744 shares of the company’s common stock and warrants to purchase up to 7,425,744 shares of common stock at a combined offering price of $1.01 per share of common stock and accompanying warrant, in a registered direct offering priced at-the-market under the Nasdaq rules. The warrants have an exercise price of $0.885 per share, exercisable at the date of issuance…

Continue Reading

WednesdayJul 19, 2023 12:33 pm

NetworkNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Continues Sales Momentum with Announcement of Three New Orders

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, has received three new sales, for a total of eight new units. The sales, which came from a military base, a mall and a university, come on the heels of a consistent stream of orders the company has received. According to the announcement, the Nellis Air Force Base is expanding the use of K1 Retrofit Kits through a Knightscope reseller; the base has 20 competitor products that have been retrofitted with Knightscope’s modern technologies. The result is extremely cost-effective systems that utilize cellular…

Continue Reading

WednesdayJul 19, 2023 12:00 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Expands Portfolio in Oral Nicotine Delivery Sector

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that it was granted a strategically important new patent in the oral nicotine sector by the United States Patent and Trademark Office (“USPTO”). According to the update, U.S. patent #11,700,875 Compositions and Methods For Sublingual Delivery of Nicotine includes claims for many types of nicotine, including nicotine benzoate, nicotine ditartrate, nicotine citrate, nicotine polacrilex, and many others, for use in sublingual delivery formats like oral pouches. The company’s superior DehydraTECH processing and sublingual compositions have now been recognized through exceptional scientific study results as well as…

Continue Reading

TuesdayJul 18, 2023 2:54 pm

NetworkNewsBreaks – Bollinger Motors, a Majority-Owned EV Truck Company of Mullen Automotive Inc. (NASDAQ: MULN), Kicks off ‘Design Validation’ Pilot Builds

Bollinger Motors, which in September of 2022 became a majority-owned EV truck company of Mullen Automotive (NASDAQ: MULN), today announced the start of its “design validation” pilot builds of the B4 all-electric Class 4 chassis cabs for testing and demonstration. According to the announcement, manufacturing of the pilot vehicles has kicked off in partnership with Roush Industries Inc. at its facility in Livonia, Michigan. The first five completed chassis cabs are expected to roll out this summer, with another 15+ vehicles by the end of the third quarter of 2023. “Bollinger Motors has over eight years of experience in developing,…

Continue Reading

TuesdayJul 18, 2023 1:38 pm

NetworkNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Enters Exclusive License Agreement with University of Pittsburgh

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has signed an exclusive license agreement with the University of Pittsburgh. The agreement grants Genprex worldwide, exclusive rights to a patent application and related technology for a gene therapy targeting both type 1 and type 2 diabetes. The therapy utilizes Pdx1 (“Pdx1”) and MafA (“MafA”) genes controlled by an MafB (“MafB”) promoter and administered through an adeno-associated virus (“AAV”) vector directly into the pancreatic duct. Preclinical data from nonhuman primate models of type 1 diabetes show promising results, with significant decreases…

Continue Reading

TuesdayJul 18, 2023 1:20 pm

NetworkNewsBreaks – IGC Pharma Inc. (NYSE American: IGC) Presenting 6 Posters on Its Lead Therapeutic Candidate at AAIC 2023

IGC Pharma (NYSE American: IGC), a clinical-stage pharmaceutical company, today announced that it is presenting six in-person posters highlighting data from its phase 1 clinical trials investigating the company’s lead therapeutic candidate, IGC-AD1, at the Alzheimer’s Association International Conference (“AAIC”). The event is taking place July 16-20, 2023, in Amsterdam, Netherlands. “We are honored to have six posters accepted for presentation at AAIC 2023, a prestigious meeting of leading Alzheimer’s disease experts and pharmaceutical innovators,” said Ram Mukunda, CEO of IGC. “The data being presented at AAIC from our phase 1 clinical trial of IGC-AD1 demonstrates the positive impact of…

Continue Reading